Integrin 6 Indicates a Poor Prognosis of Craniopharyngioma Through Bioinformatic Analysis and Experimental Validation

Overview

Journal J Oncol

Specialty Oncology

Date 2022 Oct 21

PMID 36268277

Authors

Yanfei Jia

Wentao Wu

Youchao Xiao

Kefan Cai

Songbai Gui

Qiang Li

Tian Li

Affiliations

Soon will be listed here.

Abstract

Background: Craniopharyngioma (CP) is a benign slow-growing tumor. It tends to affect children, and the number of patients is on rise. Considering the high morbidity and mortality of CP, it is urgent and pivotal to identify new biomarkers to uncover the etiology and pathogenesis of CP.

Methods: The "limma" package was utilized to calculate the data from the Gene Expression Omnibus (GEO) database. Based on differentially expressed genes (DEGs), gene ontology and pathway analysis were deduced from the DAVID web tool. Further, we constructed a protein-protein interaction (PPI) network. Weighted correlation network analysis (WGCNA) was utilized to build a coexpression network. Finally, Western blotting and survival analysis were performed to examine the expression level of important metabolism-related genes.

Results: Three hundred and eighty-four DEGs were identified between normal tissues and CPs from the GSE94349 and GSE26966 datasets. The Venn diagram for DEGs and hub genes in the 'turquoise' module revealed four key genes. Finally, the outcome of the survival analysis suggested that Integrin 6 (ITGA6) significantly affected the overall survival time of the patients with CP.

Conclusion: IGTA6, as a metabolism-related molecule, was found to be substantially related to the overall survival of patients with CP.

Citing Articles

The clinical significance of inflammatory mediators in predicting obesity and progression-free survival in patients with adult-onset Craniopharyngioma.

Xiao Y, Wu W, Liu F, Jia Y, Jin L, Qiao N BMC Cancer. 2024; 24(1):799.

PMID: 38965454 PMC: 11229012. DOI: 10.1186/s12885-024-12548-4.

Clinical Significance of Plasma Leptin and Its Receptors mRNA Expression in Craniopharyngiomas: A Prospective Study.

Xiao Y, Wu W, Cai K, Jin L, Jia Y, Qiao N Biomolecules. 2023; 13(7).

PMID: 37509115 PMC: 10377231. DOI: 10.3390/biom13071078.

References

Herring E, Kanaoka S, Tremblay E, Beaulieu J . Droplet digital PCR for quantification of in a stool mRNA assay for the detection of colorectal cancers. World J Gastroenterol. 2017; 23(16):2891-2898. PMC: 5413784. DOI: 10.3748/wjg.v23.i16.2891. View

Fernandez-Miranda J, Gardner P, Snyderman C, Devaney K, Strojan P, Suarez C . Craniopharyngioma: a pathologic, clinical, and surgical review. Head Neck. 2011; 34(7):1036-44. DOI: 10.1002/hed.21771. View

Zhang D, Yang Z, Zhou E, Miao X, Zou Q, Li J . Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma. Oncol Lett. 2017; 12(6):5136-5144. PMC: 5228576. DOI: 10.3892/ol.2016.5341. View

Edgar R, Barrett T . NCBI GEO standards and services for microarray data. Nat Biotechnol. 2006; 24(12):1471-2. PMC: 2270403. DOI: 10.1038/nbt1206-1471. View

Daubenbuchel A, Muller H . Neuroendocrine Disorders in Pediatric Craniopharyngioma Patients. J Clin Med. 2015; 4(3):389-413. PMC: 4470135. DOI: 10.3390/jcm4030389. View

Sughrue M, Yang I, Kane A, Fang S, Clark A, Aranda D . Endocrinologic, neurologic, and visual morbidity after treatment for craniopharyngioma. J Neurooncol. 2010; 101(3):463-76. PMC: 3024496. DOI: 10.1007/s11060-010-0265-y. View

Barkhoudarian G, Laws E . Craniopharyngioma: history. Pituitary. 2012; 16(1):1-8. DOI: 10.1007/s11102-012-0402-z. View

Liu J, Li H, Sun L, Wang Z, Xing C, Yuan Y . Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer. Cancer Cell Int. 2017; 17:75. PMC: 5545832. DOI: 10.1186/s12935-017-0444-4. View

Zhang H, Tao J, Sheng L, Hu X, Rong R, Xu M . RETRACTED: Twist2 promotes kidney cancer cell proliferation and invasion via regulating ITGA6 and CD44 expression in the ECM-Receptor-Interaction pathway. Biomed Pharmacother. 2016; 81:453-459. DOI: 10.1016/j.biopha.2016.02.042. View

10.

Zhu J, You C . Craniopharyngioma: Survivin expression and ultrastructure. Oncol Lett. 2014; 9(1):75-80. PMC: 4246612. DOI: 10.3892/ol.2014.2690. View

11.

Wang D, Tang L, Wu H, Wang K, Gu D . MiR-127-3p inhibits cell growth and invasiveness by targeting ITGA6 in human osteosarcoma. IUBMB Life. 2018; 70(5):411-419. DOI: 10.1002/iub.1710. View

12.

Brastianos P, Santagata S . ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma. Eur J Endocrinol. 2015; 174(4):R139-44. PMC: 4876601. DOI: 10.1530/EJE-15-0957. View

13.

Liu Y, Qi S, Wang C, Pan J, Fan J, Peng J . Pathological Relationship Between Adamantinomatous Craniopharyngioma and Adjacent Structures Based on QST Classification. J Neuropathol Exp Neurol. 2018; 77(11):1017-1023. DOI: 10.1093/jnen/nly083. View

14.

Wilhite S, Barrett T . Strategies to explore functional genomics data sets in NCBI's GEO database. Methods Mol Biol. 2011; 802:41-53. PMC: 3341798. DOI: 10.1007/978-1-61779-400-1_3. View

15.

Laudato S, Patil N, Abba M, Leupold J, Benner A, Gaiser T . P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1. Int J Cancer. 2017; 141(9):1879-1890. DOI: 10.1002/ijc.30854. View

16.

Mortini P . Craniopharyngiomas: a life-changing tumor. Endocrine. 2016; 57(2):191-192. DOI: 10.1007/s12020-016-1192-2. View

17.

Garnett M, Puget S, Grill J, Sainte-Rose C . Craniopharyngioma. Orphanet J Rare Dis. 2007; 2:18. PMC: 1855047. DOI: 10.1186/1750-1172-2-18. View

18.

Savateev A, Trunin Y, Mazerkina N . [Radiotherapy and radiosurgery in treatment of craniopharyngiomas]. Zh Vopr Neirokhir Im N N Burdenko. 2017; 81(3):94-106. DOI: 10.17116/neiro201781394-106. View

19.

Zhang H, Tao J, Sheng L, Hu X, Rong R, Xu M . Twist2 promotes kidney cancer cell proliferation and invasion by regulating ITGA6 and CD44 expression in the ECM-receptor interaction pathway. Onco Targets Ther. 2016; 9:1801-12. PMC: 4821395. DOI: 10.2147/OTT.S96535. View

20.

Su G, Morris J, Demchak B, Bader G . Biological network exploration with Cytoscape 3. Curr Protoc Bioinformatics. 2014; 47:8.13.1-24. PMC: 4174321. DOI: 10.1002/0471250953.bi0813s47. View